Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries
Errataetall: |
CommentIn: N Engl J Med. 1997 Sep 18;337(12):847-9. - PMID 9295243 |
---|---|
Medienart: |
Artikel |
Erscheinungsjahr: |
1997 |
---|---|
Erschienen: |
1997 |
Enthalten in: |
Zur Gesamtaufnahme - volume:337 |
---|---|
Enthalten in: |
The New England journal of medicine - 337(1997), 12 vom: 18. Sept., Seite 853-6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lurie, P [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 18.09.1997 Date Revised 21.11.2013 published: Print CommentIn: N Engl J Med. 1997 Sep 18;337(12):847-9. - PMID 9295243 Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM092480608 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM092480608 | ||
003 | DE-627 | ||
005 | 20231222090904.0 | ||
007 | tu | ||
008 | 231222s1997 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0309.xml |
035 | |a (DE-627)NLM092480608 | ||
035 | |a (NLM)9295246 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lurie, P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries |
264 | 1 | |c 1997 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 18.09.1997 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a CommentIn: N Engl J Med. 1997 Sep 18;337(12):847-9. - PMID 9295243 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biomedical and Behavioral Research | |
650 | 4 | |a Centers for Disease Control and Prevention | |
650 | 4 | |a Council for International Organizations of Medical Sciences | |
650 | 4 | |a Health Care and Public Health | |
650 | 4 | |a National Institutes of Health | |
650 | 4 | |a Americas | |
650 | 4 | |a Clinical Research | |
650 | 4 | |a Clinical Trials | |
650 | 4 | |a Critique | |
650 | 4 | |a Developed Countries | |
650 | 4 | |a Developing Countries | |
650 | 4 | |a Diseases | |
650 | 4 | |a Ethics | |
650 | 4 | |a Hiv Infections | |
650 | 4 | |a North America | |
650 | 4 | |a Northern America | |
650 | 4 | |a Research Methodology | |
650 | 4 | |a Treatment | |
650 | 4 | |a United States | |
650 | 4 | |a Vertical Transmission | |
650 | 4 | |a Viral Diseases | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
650 | 7 | |a Placebos |2 NLM | |
650 | 7 | |a Zidovudine |2 NLM | |
650 | 7 | |a 4B9XT59T7S |2 NLM | |
700 | 1 | |a Wolfe, S M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 337(1997), 12 vom: 18. Sept., Seite 853-6 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
773 | 1 | 8 | |g volume:337 |g year:1997 |g number:12 |g day:18 |g month:09 |g pages:853-6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 337 |j 1997 |e 12 |b 18 |c 09 |h 853-6 |